Start a new topic

Molecular Markers for Cell Type Identification

As part of our ongoing work within the RMIP (Regenerative Medicine Innovation Project) community, we want to initiate a structured effort to develop a shared list of cellular markers that can be applied consistently across our studies. The goal of this thread is to gather input, critically assess existing knowledge, and work toward a consensus reference set that strengthens reproducibility and cross-study comparison.


Scope and Context

This effort is focused on regenerative medicine research within RMIP, with special attention to markers used for:


  • Identifying and characterizing stem/progenitor cell populations
  • Tracking differentiation trajectories during tissue repair and regeneration
  • Evaluating immune and stromal cell contributions within regenerative contexts
  • Ensuring robust cross-validation of emerging biomarkers between in vitro, in vivo, and preclinical/translational studies


We are not aiming to propose an exhaustive catalog of all known cellular markers, but instead to build a practical set of well-validated, context-relevant markers that multiple RMIP teams can rely on.


Cell Types of Interest 

Based on ongoing RMIP priorities, some of the populations we anticipate needing consensus markers for include:


  • Stem and progenitor cells
    • Hematopoietic stem and progenitor cells (HSPCs)
    • Tissue-specific progenitors (e.g., neural progenitors, cardiac progenitors, epithelial stem cells)
  • Differentiated and lineage-committed cells
  • Supportive microenvironment populations
  • Immune modulatory cells in regeneration


Key Considerations for Marker Selection 

  1. Specificity: Does the marker uniquely identify the intended stem, progenitor, or differentiated lineage?
  2. Sensitivity: Is the marker robust enough to detect rare populations during regeneration?
  3. Context-dependence: Are these markers consistent across in vitro culture, preclinical models, and human tissues?
  4. State vs. Identity: Some markers indicate activation or differentiation status rather than lineage identity. We should clarify when markers define cell identity versus functional state.
  5. Stability Across Platforms: Do markers perform consistently across modalities such as flow cytometry, immunostaining, RNA-seq validation, or proteomic approaches?


Call to Action:

Please share your experiences, preferred sets of markers, and any challenges you’ve encountered. It would be especially helpful if you can highlight:

  • Markers you’ve found most reliable for distinguishing specific subtypes.
  • Situations where marker sensitivity or specificity was problematic.
  • Literature references.

By pooling our knowledge, we can build a consensus marker framework that supports all RMIP investigators and ensures stronger interoperability across our studies.


Looking forward to your perspectives and contributions!

Login or Signup to post a comment